Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25042232 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Michihisa Jougasaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan. Hauptthemen laut MEDLINE: Interleukin-6, Myxoma. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHO Collaborative Clinical Research.
Abstract (Originalsprache)
Plasma concentrations of a pleiotropic cytokine, interleukin (IL)-6, are increased in patients with cardiac myxoma. We investigated the regulation of IL-6 in cardiac myxoma. Immunohistochemical staining and reverse transcription-polymerase chain reaction (RT-PCR) revealed that IL-6 and its receptors, IL-6 receptor (IL-6R) and gp130, co-existed in the myxoma cells. Myxoma cells were cultured, and an antibody array assay showed that a conditioned medium derived from the cultured myxoma cells contained increased amounts of IL-6. Signal transducer and activator of transcription (STAT) 3 and Akt were constitutively phosphorylated in the myxoma cells. An enzyme-linked immunosorbent assay (ELISA) showed that the myxoma cells spontaneously secreted IL-6 into the culture medium. Real-time PCR revealed that stimulation with IL-6 + soluble IL-6R (sIL6R) significantly increased IL-6 mRNA in the myxoma cells. Pharmacological inhibitors of STAT3 and Akt inhibited the IL-6 + sIL-6R-induced gene expression of IL-6 and the spontaneous secretion of IL-6. In addition, IL-6 + sIL-6R-induced translocation of phosphorylated STAT3 to the nucleus was also blocked by STAT3 inhibitors. This study has demonstrated that IL-6 increases its own production via STAT3 and Akt pathways in cardiac myxoma cells. Autocrine regulation of IL-6 may play an important role in the pathophysiology of patients with cardiac myxoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Clinical Research, NHO Kagoshima Medical Center, Kagoshima 892-0853, Japan.
ORCID-Profile: Michihisa Jougasaki
Förderung
- NHO Collaborative Clinical Research
Zitieren
APA
Jougasaki, M., Takenoshita, Y., Umebashi, K., Yamamoto, M., Sudou, K., Nakashima, H., Sonoda, M., & Kinjo, T. (2024). Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042232
Vancouver
Jougasaki M, Takenoshita Y, Umebashi K, Yamamoto M, Sudou K, Nakashima H, et al. Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042232
BibTeX
@article{Jougasaki2024,
author = {Jougasaki, Michihisa and Takenoshita, Yoko and Umebashi, Katsuyuki and Yamamoto, Masayoshi and Sudou, Ku and Nakashima, Hitoshi and Sonoda, Masahiro and Kinjo, Tamahiro},
title = {Autocrine Regulation of Interleukin-6 via the Activation of STAT3 and Akt in Cardiac Myxoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25042232}
}
EUVIMED